Skip to Content
Merck
CN

SML4064

Sigma-Aldrich

Ac-Abu-Tle-Leu-Gln-AFC

≥95% (HPLC)

Synonym(s):

Ac-Abu-Tle-LQ-AFC (Abu=2-Aminobutyrate, Tle=t-Butylglycine, AFC = 4-trifluoromethylcoumaryl-7-amide), Ac-QS1-AFC, Acetyl-L-α-aminobutyroyl-L-tert-leucyl-L-leucyl-L-glutamine-α-(4-trifluoromethylcoumaryl-7-amide)

Sign Into View Organizational & Contract Pricing

Select a Size


Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Level

Assay

≥95% (HPLC)

form

(Powder or Lyophilized powder or film)

storage condition

desiccated

color

white to off-white

storage temp.

-10 to -25°C

SMILES string

CC(N[C@H](C(N[C@H](C(C[C@H](C(N[C@H](C(NC1=CC2=C(C=C1)C(C(F)(F)F)=CC(O2)=O)=O)CCC(N)=O)=O)CC(C)C)=O)C(C)(C)C)=O)CC)=O

InChI

1S/C34H46F3N5O8/c1-8-23(39-18(4)43)31(48)42-29(33(5,6)7)25(44)14-19(13-17(2)3)30(47)41-24(11-12-27(38)45)32(49)40-20-9-10-21-22(34(35,36)37)16-28(46)50-26(21)15-20/h9-10,15-17,19,23-24,29H,8,11-14H2,1-7H3,(H2,38,45)(H,39,43)(H,40,49)(H,41,47)(H,42,48)/t19

InChI key

VWVFVJSQWAXHGY-RYRALHHHSA-N

Biochem/physiol Actions

Kinetically preferred fluorogenic substrate for detecting SARS-CoV and SARS-CoV-2 main proteases (Mpro; 3CLpro) activity (ex 380+/-20 nm, em 500+/-20 nm).
Ac-QS1-AFC or Ac-Abu-Tle-Leu-Gln-AFC (Abu = Aminobutyrate; Tle = t-Butylglycine; AFC= 7-amino-4-trifluoromethyl coumarin) is a kinetically preferred fluorogenic substrate for the detection of SARS-CoV and SARS-CoV-2 main protease (Mpro; 3CLpro) activity. Mpro cleavage results in the release of the C-terminal AFC and increased fluorescence (ex 380+/-20 nm, em 500+/-20 nm).

Disclaimer

Hygroscopic

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease
PLoS ONE, 16(2) (2021)
Wioletta Rut et al.
Nature chemical biology, 17(2), 222-228 (2020-10-24)
In December 2019, the first cases of infection with a novel coronavirus, SARS-CoV-2, were diagnosed. Currently, there is no effective antiviral treatment for COVID-19. To address this emerging problem, we focused on the SARS-CoV-2 main protease that constitutes one of

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service